Plexus Corp. (NASDAQ:PLXS) Stock Has Consensus Price Target of $276.86 According to Analysts

Plexus Corp. (NASDAQ:PLXS) has been given an average recommendation of “Buy” by the eight research firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $276.86.

PLXS has been the subject of several research reports. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Stifel Nicolaus upped their target price on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target for the company in a research note on Friday, July 31st. Weiss Ratings lowered Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, September 9th. Finally, Wall Street Zen cut Plexus from a “buy” rating to a “hold” rating in a research note on Saturday.

Insider Activity at Plexus

In related news, Director Michael V. Schrock sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the transaction, the director directly owned 40,329 shares of the company’s stock, valued at approximately $11,090,475. The trade was a 9.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $242.41, for a total value of $363,615.00. Following the transaction, the chief executive officer directly owned 64,388 shares in the company, valued at $15,608,295.08. The trade was a 2.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,500 shares of company stock worth $1,960,520. Insiders own 1.78% of the company’s stock.

Institutional Investors Weigh In On Plexus

Institutional investors have recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Plexus during the 2nd quarter worth approximately $32,000. Kilter Group LLC acquired a new position in Plexus in the 2nd quarter valued at $40,000. Integrated Wealth Concepts LLC bought a new position in Plexus during the 2nd quarter worth $51,000. Persistent Asset Partners Ltd bought a new position in Plexus during the 2nd quarter worth $71,000. Finally, Covestor Ltd lifted its holdings in shares of Plexus by 207.7% during the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock worth $35,000 after buying an additional 162 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Plexus Price Performance

PLXS stock opened at $263.09 on Wednesday. The stock has a 50-day moving average price of $253.01 and a two-hundred day moving average price of $250.95. The stock has a market cap of $7.04 billion, a PE ratio of 38.80 and a beta of 0.89. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06. Plexus has a 1 year low of $132.03 and a 1 year high of $307.06.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping the consensus estimate of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The company had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same period in the prior year, the firm earned $1.64 earnings per share. Plexus’s revenue for the quarter was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities analysts forecast that Plexus will post 7.13 EPS for the current fiscal year.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: KeyCorp reiterated an Overweight rating and a $300 price target, implying additional upside from recent levels. The firm forecasts Plexus will earn $7.18 per share in fiscal 2026 and $8.74 per share in fiscal 2027, with quarterly EPS estimates rising from $2.01 in Q1 2027 to $2.35 in Q4 2027. Those projections point to continued earnings growth.
• Positive Sentiment: The latest quarterly results provide support for the bullish outlook: Plexus previously exceeded EPS and revenue expectations, reporting $2.32 in EPS on $1.30 billion of revenue, with revenue up 28.2% year over year.
• Neutral Sentiment: A report stated that Plexus was the subject of a significant increase in short interest, but also listed total short interest at zero shares and a days-to-cover ratio of 0.0. The data appears internally inconsistent, so it offers little reliable insight into current trading sentiment.
• Negative Sentiment: A Seeking Alpha analysis argues that Plexus’s growth must be accompanied by stronger cash generation. The article’s focus on cash conversion signals a potential concern for investors even as revenue and earnings expand, particularly because the stock trades at a relatively elevated valuation of about 39 times earnings. Plexus: Growth Has Arrived, But The Cash Must Follow

About Plexus

Plexus Corp. is a global electronics manufacturing services company that designs, manufactures and services products for original equipment manufacturers. The company supports customers across the product life cycle, from product development and engineering to supply chain management, assembly, testing, fulfillment and aftermarket services.

Plexus provides solutions for industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.